Department of Medicine Faculty

Bio

Administrator Info
Name: Kathy Vang
Email: vang3630@umn.edu
Mail: 420 Delaware Street SE
MMC 508 Mayo
8508A (Campus Delivery Code)
Minneapolis, MN 55455

Summary
Born in London, UK, Dr. Yannopoulos received his M.D. from the University of Athens in Greece. He completed his medicine residency and general-cardiology fellowship at the University of Minnesota. Following an interventional-cardiology fellowship at Johns Hopkins University in Baltimore, Maryland, Dr. Yannopoulos joined the University of Minnesota faculty in 2008. In March 2010, he became the research director for interventional cardiology.Dr. Yannopoulos is board-certified in internal medicine, cardiology, and interventional cardiology. His clinical interests include emergent cardiac care, coronary-artery disease, and congenital and peripheral intervention.Dr. Yannopoulos's research involves cardiopulmonary resuscitation, hypothermia, and myocardial salvage during acute coronary syndromes. He is considered an authority in cardiorespiratory interactions and hypothermia during CPR. His work in the laboratories of Dr. Keith Lurie (at the University of Minnesota) and Dr. Henry Halperin (at Johns Hopkins University) has helped change current CPR practices.Dr. Yannopoulos is a member of the American Heart Association's CPR guidelines-writing committee, and of the basic life support and research working-group subcommittees. He also serves on the organization committee for the AHA's Resuscitation Science Symposium (ReSS), the largest international conference addressing CPR and emergent cardiac/trauma care.Dr. Yannopoulos is the recipient of two American Heart Association Young Investigator awards (2005 and 2008), and has received AHA and NIH grant support for his work in CPR devices designed to improve bloodflow and clinical outcomes.

Clinical Summary

• Coronary artery disease and intervention
• CPR
• Interventional cardiology
• Peripheral vascular disease
• Resuscitation
• Structural heart disease

Bio

I am a medical oncologist with a specialty in breast cancer. My laboratory has been interested in the regulation of cancer cells by the insulin-like growth factors (IGFs) and insulin. I also maintain an active clinical practice in the medical management of breast cancer. As part of my clinical care, I also serve as the site principal investigator on several clinical trials that employ experimental therapies targeted against IGF receptor and the PI3K pathway. I am chair in of the Agent Selection Committee of I-SPY2 and I also serve on the Executive Committee of this trial designed to validate investigational therapies in the neoadjuvant treatment of breast cancer. I have been the director of the Masonic Cancer Center since 2007. I have maintained these clinical, translational, and research activities to best identify strategies for improved outcomes in cancer.

Research Summary

Administrator Info
Name: Marina Sladojevic
Phone: 612-626-5475
Email: marinas@umn.edu
Mail: Masonic Cancer Center, University of Minnesota
420 Delaware Street SE
MMC 806
Minneapolis, MN 55455

Summary

My laboratory has been interested in the regulation of cancer cells by insulin and the insulin-like growth factors ( IGFs ). Our laboratory was one of the first to show a role for this pathway in Ewing's sarcoma and breast cancer. The laboratory remains focused on the signaling pathways regulated by the IGFs that are relevant to cancer biology. We have shown that IGF signaling is dependent on activation of specific adaptor proteins and downstream signaling molecules. Our lab is also evaluating the role for the fetal isoform of the insulin receptor (IR-A) in breast cancer biology. Interactions between estrogen receptor expressing breast cancers and insulin/IGFs result in enhanced growth and increased survival. While some anti-IGF strategies have been tested in clinical trials, toxicities and lack of targeting of IR-A has limited the clinical efficacy and the laboratory is working on strategies to target IR-A specifically without inhibition of the adult isoform of insulin receptor (IR-B).

Clinical Summary

Breast cancer

Bio

Administrator Info
Name: Admin
Phone: 612-624-9996
Fax: 612-625-4410
Email: idimdivision@umn.edu
Mail: Mayo Memorial Building, MMC 250, 420 Delaware Street S.E., Minneapolis, MN 55455

Summary
Jo-Anne Young (née van Burik), M.D., is a Professor of Medicine and Medical Director of the Program in Adult Transplant Infectious Disease. She joined the faculty in 1999. She received both her B.A. and M.D. from Case Western Reserve University and completed a residency in Medicine at Vanderbilt University Medical Center. Her fellowship in Infectious Disease and several years of junior faculty service were at the University of Washington with the Fred Hutchinson Cancer Research Center. Dr. Young's primary area of interest is bringing diagnostic and treatment opportunities to the bedside for transplant patients. She has worked on developing diagnostic testing for complicated fungal infections of the immunocompromised host. Currently, Dr. Young is lead investigator at the University of Minnesota for multiple clinical trials on bacterial, viral, and fungal agents, as well as vaccines and a T cell prevention study, for transplant patients.

Clinical Summary

• Viral infections
• Fungal infections
• Transplant recipients
• Immune compromised persons

Bio

Administrator Info
Name: DHM Admin Team
Email: dhmadmin@umn.edu
Phone Number: 612-624-0579
Fax Number: 612-624-3189

Summary
I graduated from the University of Minnesota Internal Medicine and Pediatrics residency program in June 2020. I also graduated as part of both the internal medicine and the pediatrics global health pathways. I have a clinical interest in hospital medicine as well as global health and caring for underserved populations.

Clinical Summary

Global Heath

Bio

Administrator Info
Email: endofixer@umn.edu
Mail: 420 Delaware ST SE
MMC 101
Minneapolis, MN 55455

Summary
Dr. Kidmealem Zekarias is Assistant Professor of Medicine at the Division of Diabetes, Endocrinology and Metabolism at the University of Minnesota. Her work focuses on clinical care in adult endocrinology. She completed her residency at Marshfield clinic/St Joseph Hospital and Wayne State University. She is board certified in internal medicine and has been working as an internist and primary care physician before she joined fellowship in endocrinology. She is board certified in Endocrinology.

Research Summary

Research interest areas and areas of publications include: management of Type 2 diabetes, continuous glucose monitoring in Type 1 diabetes, hypoglycemia in diabetes patients, male reproductive health and adrenal disease.

Teaching Summary

• Adrenal disorders

Clinical Summary

All areas of adult endocrinology including: Diabetes, Thyroid disease, adrenal disorders, calcium and bone disorders, male and female reproductive disorders, lipid, obesity and pituitary disorder.

Bio

Administrator Info
Name: DHM Admin Team
Email: dhmadmin@umn.edu
Phone Number: 612-624-0579
Fax Number: 612-624-3189

Summary
Dr. Zewde is a University of Minnesota Assistant Professor of Medicine, general medicine hospitalist. He received his medical training at University of Gondar Medical School in Ethiopia and also worked as a general practitioner. He worked for the Ethiopian Ministry of health on general public health issues and was faculty at the University of Gondar. Project Manager from 2009-2011 Collaborator of University of Washington Global Health Department, Gondar College of Medicine and Health Science Gondar, Ethiopia. Educator and mentor for visiting MPH students in SCOPE Project (Strengthening Care Opportunities through Partnership in Ethiopia).Lecturer, School of Public Health from 2009-2011 at Gondar College of Medicine and Health Science Gondar, Ethiopia. He finished his Internal medicine residency at UMN in 2016 where he joined to work has a faculty within the division of general internal medicine. His areas of interests are in global health partnership.

Research Summary

• Global health partnership
• Health disparities and medical education

Teaching Summary

• Global health

• Working with FMGs

Clinical Summary

• Travel and tropical medicine
• Global health
• Hospital Medicine

Bio

Administrator Info
Name: Jordan Knapp
Email: jknapp@umn.edu

Summary
Dr. Zorko received his MD and PhD at The Ohio State University in Columbus, Ohio, where he first became interested in bone marrow transplantation and cellular therapies. He then completed his clinical residency and fellowship at the University of Minnesota Medical Center. His primary research interest is development of novel natural killer cells and immune engagers to treat solid tumors, with a particular focus on castration-resistant prostate cancer. He sees genitourinary oncology patients in the clinic and attends on the inpatient bone marrow transplant/cellular therapy team

Research Summary

• Natural Killer cell therapeutic development
• Solid tumor microenvironment
• Immune therapies for castration-resistant prostate cancer

Teaching Summary

• Pre-medical mentoring
• clinical education

Clinical Summary

• Prostate cancer
• bladder cancer
• cellular/immunotherapy clinical trials